全文获取类型
收费全文 | 4271456篇 |
免费 | 354989篇 |
国内免费 | 15253篇 |
专业分类
耳鼻咽喉 | 60891篇 |
儿科学 | 132913篇 |
妇产科学 | 111749篇 |
基础医学 | 654542篇 |
口腔科学 | 118685篇 |
临床医学 | 387334篇 |
内科学 | 774752篇 |
皮肤病学 | 103212篇 |
神经病学 | 366107篇 |
特种医学 | 170502篇 |
外国民族医学 | 912篇 |
外科学 | 651505篇 |
综合类 | 126073篇 |
现状与发展 | 23篇 |
一般理论 | 2579篇 |
预防医学 | 361926篇 |
眼科学 | 100390篇 |
药学 | 301602篇 |
24篇 | |
中国医学 | 11355篇 |
肿瘤学 | 204622篇 |
出版年
2021年 | 55631篇 |
2020年 | 35457篇 |
2019年 | 58569篇 |
2018年 | 73130篇 |
2017年 | 55853篇 |
2016年 | 62162篇 |
2015年 | 75473篇 |
2014年 | 110191篇 |
2013年 | 175497篇 |
2012年 | 117193篇 |
2011年 | 120201篇 |
2010年 | 122740篇 |
2009年 | 125933篇 |
2008年 | 107421篇 |
2007年 | 113922篇 |
2006年 | 123452篇 |
2005年 | 118615篇 |
2004年 | 119561篇 |
2003年 | 110291篇 |
2002年 | 100914篇 |
2001年 | 154277篇 |
2000年 | 150433篇 |
1999年 | 139513篇 |
1998年 | 71249篇 |
1997年 | 67734篇 |
1996年 | 65618篇 |
1995年 | 61482篇 |
1994年 | 55561篇 |
1993年 | 51595篇 |
1992年 | 103554篇 |
1991年 | 98938篇 |
1990年 | 94041篇 |
1989年 | 91675篇 |
1988年 | 85297篇 |
1987年 | 83764篇 |
1986年 | 79457篇 |
1985年 | 77896篇 |
1984年 | 65932篇 |
1983年 | 58842篇 |
1982年 | 48127篇 |
1981年 | 44869篇 |
1980年 | 42162篇 |
1979年 | 57821篇 |
1978年 | 47027篇 |
1977年 | 41589篇 |
1976年 | 38650篇 |
1975年 | 37843篇 |
1974年 | 42413篇 |
1973年 | 40546篇 |
1972年 | 38014篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
951.
952.
Erin L. Sutfin Jennifer Cornacchione Ross Allison J. Lazard Elizabeth Orlan Cynthia K. Suerken Kimberly D. Wiseman 《Health communication》2019,34(3):343-351
ABSTRACTAdolescents and young adults smoke waterpipe tobacco (WT) and cigarillos, at least in part, based on erroneous beliefs that these products are safer than cigarettes. To address this challenge, we used a systematic, three-phase process to develop a health communication campaign to discourage WT and cigarillo smoking among at-risk (tobacco users and susceptible non-users) 16- to 25-year-olds. In Phase 1, we used a national phone survey (N = 896) to determine salient message beliefs. Participants reported constituents (i.e., harmful chemicals) emitted by the products were worrisome. In Phase 2, we developed and evaluated four message executions, with varying imagery, tone, and unappealing products with the same constituents, using focus groups (N = 38). Participants rated one execution highly, resulting in our development of a campaign where each message: (1) identified a tobacco product and constituent in the smoke; (2) included an image of an unappealing product containing the constituent (e.g., pesticides, gasoline) to grab attention; and (3) used a humorous sarcastic tone. In Phase 3, we tested the campaign messages (17 intervention and six control) with a nationally representative online survey (N = 1,636). Participants rated intervention and control messages highly with few differences between them. Exposure to messages resulted in significant increases in all risk beliefs from pre to post (p < 0.05). For WT, intervention messages increased beliefs about addiction more than control messages (p < 0.05). This systematic, iterative approach resulted in messages that show promise for discouraging WT and cigarillo use. 相似文献
953.
954.
955.
Prolidase deficiency is a rare autosomal recessive disorder characterized by cutaneous ulcers, facial dysmorphism, recurrent infections, and intellectual disability. We report a unique case of a 6‐year‐old boy with prolidase deficiency and Crohn's disease who presented with lower extremity ulcers. Cutaneous ulcers due to prolidase deficiency are historically resistant to treatment, and we report success with the novel use of topical tacrolimus. 相似文献
956.
J.J. Crowley R.B. Warren J.C. Cather 《Journal of the European Academy of Dermatology and Venereology》2019,33(9):1676-1684
Psoriasis is a chronic disease that requires long‐term treatment. Consequently, understanding the safety and tolerability of any potential treatment over time is critical to effective prescribing. The biologic agents currently available for the treatment of psoriasis target a number of different inflammatory cytokines involved in psoriasis disease pathogenesis. The monoclonal antibodies tildrakizumab, guselkumab and risankizumab target the p19 subunit that is specific to interleukin (IL)‐23. This article reviews published data on the safety of these IL‐23p19 inhibitors in patients with psoriasis compared with other currently available biologic therapies. Data from randomized, placebo‐ and active‐controlled phase 3 clinical trials show tildrakizumab, guselkumab and risankizumab to have a favourable risk–benefit profile in patients with moderate to severe psoriasis. No significant safety concerns have been observed for any of these IL‐23p19 inhibitors in the data published to date. The most commonly reported adverse events (AEs) associated with these agents in phase 3 studies were upper respiratory tract infections. No increase was seen in rates of serious infections, malignancies or major adverse cardiovascular events, with no signals suggestive of an elevated risk of opportunistic infections, active tuberculosis or reactivation of latent tuberculosis infection, mucocutaneous Candida infections, triggering or worsening of inflammatory bowel disease, demyelinating disorders or suicidal ideation. Selectively targeting IL‐23p19 may help avoid AEs that have been associated with biologic agents with other mechanisms of action. Data from long‐term extension studies and patient registries will further establish the safety profile of IL‐23p19 inhibitors for the treatment of moderate to severe psoriasis in routine practice. 相似文献
957.
Schizophrenia is a chronic and severe psychiatric disorder that has profound impact on an individual’s life and on society. Thus, developing more effective therapeutic interventions is essential. Over the past quarter‐century, an abundance of evidence from pharmacologic challenges, post‐mortem studies, brain imaging, and genetic studies supports the role of glutamatergic dysregulation in the pathophysiology of schizophrenia, and the results of recent randomized clinical trials based on this evidence have yielded promising results. In this article, we review the evidence that alterations in glutamatergic neurotransmission, especially focusing on the N‐methyl‐d ‐aspartate receptor (NMDAR) function, may be a critical causative feature of schizophrenia, how this contributes to pathologic circuit function in the brain, and how these insights are revealing whole new avenues for treatment development that could reduce treatment‐resistant symptoms, which account for persistent disability. 相似文献
958.
959.
Bryan E.K. Guevara Suhail Saleem Wan‐Ting Chen Pa‐Fan Hsiao Yu‐Hung Wu 《Journal of cutaneous pathology》2019,46(5):347-352
Lucio phenomenon is an atypical reaction of leprosy, characterized by vasculitic lesions that can mimic antiphospholipid syndrome (APS) clinically. Distinguishing the two can be difficult as antiphospholipid autoantibodies may be present in patients with leprosy. We report on a 32‐year‐old female patient presenting with a sudden onset of fever, hemorrhagic bullae, and skin necrosis on her lower legs. She was treated for APS due to the presence of antiphospholipid antibodies but had an inadequate response. A skin biopsy revealed thrombotic vasculopathy and necrotizing vasculitis associated with aggregation of foam cells in the perivascular area and subcutis, with acid‐fast bacilli in the histiocytes and blood vessel walls. Direct immunofluorescence showed IgM, C3, and fibrinogen deposition in the superficial and deep dermal blood vessels. The pathology confirmed the diagnosis of Lucio phenomenon, and appropriate therapy was given. It is essential to evaluate the patient comprehensively, including clinical, serological, and pathological aspects, to obtain the correct diagnosis. 相似文献
960.